These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1175161)

  • 1. Commentary. The role of structure-activity studies in the design of antitumor agents.
    Cain BF
    Cancer Chemother Rep; 1975; 59(4):679-83. PubMed ID: 1175161
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationships for thiolytic cleavage rates of antitumor drugs in the 4'-(9-acridinylamino)methanesulfonanilide series.
    Cain BR; Wilson WR; Baguley BC
    Mol Pharmacol; 1976 Nov; 12(6):1027-35. PubMed ID: 1004488
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and cytotoxic activity of pyridylthio, pyridylsulfinyl, and pyridylsulfonyl methyl acrylates.
    Phillips OA; Nelson LA; Knaus EE; Allen TM; Fathi-Afshar R
    Drug Des Deliv; 1989 Mar; 4(2):121-7. PubMed ID: 2765104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship investigation of bis(2-chloroethyl)aminoethyl esters of some carboxylic acids.
    Pajeva I; Manolov I; Golovinsky EV
    Pharmazie; 1990 May; 45(5):361-3. PubMed ID: 2395899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,2'-O-cyclocytidine, an antitumor cytidine analog resistant to cytidine deaminase.
    Hoshi A; Kanazawa F; Kuretani K; Saneyoshi M; Arai Y
    Gan; 1971 Apr; 62(2):145-6. PubMed ID: 5114632
    [No Abstract]   [Full Text] [Related]  

  • 6. Some antitumor agents derived from benzaldehyde nitrogen mustards.
    Florvall L
    Acta Pharm Suec; 1970 Apr; 7(2):87-104. PubMed ID: 5421623
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterosubstituted anthracene-9,10-dione analogues. The synthesis and antitumor evaluation of 5,8-bis[(aminoalkyl)amino]naphtho[2,3-b] thiophene-4,9-diones.
    Krapcho AP; Petry ME; Hacker MP
    J Med Chem; 1990 Sep; 33(9):2651-5. PubMed ID: 2391703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 4-hydroperoxy derivatives of ifosfamide and trofosfamide by direct ozonation and preliminary antitumor evaluation in vivo.
    Hohorst HJ; Peter G; Struck RF
    Cancer Res; 1976 Jul; 36(7 PT 1):2278-81. PubMed ID: 945124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor effect of complex compounds of tetravalent platinum].
    Konovalova AL; Presnov MA; Zheligovskaia NN; Treshchalina EM
    Dokl Akad Nauk SSSR; 1977; 234(1):223-6. PubMed ID: 880861
    [No Abstract]   [Full Text] [Related]  

  • 10. New anticancer agents: chiral isomers of ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazine-7-car bamate .
    Temple C; Rener GA
    J Med Chem; 1989 Sep; 32(9):2089-92. PubMed ID: 2769680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of mutagenicity, antitumor activity, and chemical properties of selected nitrosoureas and nitrosoamides.
    Brundrett RB; Colvin M; White EH; McKee J; Hartman PE; Brown DL
    Cancer Res; 1979 Apr; 39(4):1328-33. PubMed ID: 421216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential antitumor agents. VI. Bisquaternary salts.
    Atwell GJ; Cain BF
    J Med Chem; 1968 Mar; 11(2):295-300. PubMed ID: 5663621
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential antitumor agents. VII. Bisquaternary salts.
    Atwell GJ; Cain BF; Seelye RN
    J Med Chem; 1968 Mar; 11(2):300-5. PubMed ID: 5663622
    [No Abstract]   [Full Text] [Related]  

  • 14. Polyamine analogues with antitumor activity.
    Edwards ML; Prakash NJ; Stemerick DM; Sunkara SP; Bitonti AJ; Davis GF; Dumont JA; Bey P
    J Med Chem; 1990 May; 33(5):1369-75. PubMed ID: 2329556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of seleno- and thio-guanine-Pt (II) complexes and their antitumor activity in mice.
    Maeda M; Abiko N; Sasaki T
    Nucleic Acids Symp Ser; 1979; (6):s31-4. PubMed ID: 547237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis of flavones cytotoxic against L1210 cells].
    Ryu SH; Yoo BT; Ahn BZ; Pack MY
    Arch Pharm (Weinheim); 1985 Jul; 318(7):659-61. PubMed ID: 4038010
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relationships between the structure and carcinostatic effect of p-benzoquinone hydrazone derivatives in experimental murine leukemia L 1210].
    Schulze W; Jungstand W; Gutsche W; Wohlrabe K; Horn G
    Pharmazie; 1978; 33(2-3):111-3. PubMed ID: 674294
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).
    Woodman RJ
    Cancer Chemother Rep 2; 1974 Mar; 4(1):45-52. PubMed ID: 4826499
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice.
    Hatheway GJ; Hansch C; Kim KH; Milstein SR; Schmidt CL; Smith RN; Quinn FR
    J Med Chem; 1978 Jun; 21(6):563-74. PubMed ID: 671453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biologic examination of some derivatives of 2,2'-anhydro-1-(beta-d-arabinofuranosyl)cytosine hydrochloride (NSC-145668).
    Moffatt JG; Hamamura EK; Russell AF; Prystasz M; Verheyden JP; Yamaguchi K; Uchida N; Sato K; Nishiyama S; Shiratori O; Katagiri K
    Cancer Chemother Rep; 1974; 58(4):451-69. PubMed ID: 4854565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.